logo-loader
viewEMMAC Life Sciences

EMMAC Life Sciences expanding on its medical cannabis acquisitions in London, Portugal, and Spain

EMMAC Life Sciences CEO Antonio Costanzo sat down with Proactive at the Cannabis Europa: Transatlantic Forum in Toronto. 

The London, UK-based medical cannabis company has raised a total of £34 in the past year. It has cultivation operations in Portugal, with extraction and distribution in Spain and in the UK.

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Matinas BioPharma welcomes two 'huge' catalysts for the...

Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) Chief Medical Officer Dr Terry Ferguson tells Proactive two 'huge' catalysts for the omega-3 class transpired last week. Dr Ferguson explains how Amarin Corporation's (NASDAQ:AMRN) meetings with an FDA advisory committee and with the American...

1 hour, 14 minutes ago

2 min read